Turn Therapeutics director granted 71,666 stock options
Turn Therapeutics director Martin William Dewhurst received a grant of stock options covering 71,666 shares of Common Stock at an exercise price of $5.75 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Turn Therapeutics director Martin William Dewhurst received a grant of stock options covering 71,666 shares of Common Stock at an exercise price of $5.75 per share. The options vest in twelve equal monthly installments beginning on June 30, 2026 and expire on June 4, 2036.
Following this award, he holds 71,666 stock options directly, all tied to continued employment and the terms of the 2025 Omnibus Incentive Plan.
Insider Trade Summary
Grant/Award: 71,666 shares
Grant/Award
1 txn
Insider
Dewhurst Martin William
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock option (right to buy) | 71,666 | $0.00 | $0.00 |
Holdings After Transaction:
Stock option (right to buy) — 71,666 contracts (Direct)
Footnotes (1)
- F1. The option will vest in twelve (12) equal monthly installments, on the last day of each calendar month, commencing on June 30, 2026, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan.
Key Figures
Options granted: 71,666 options
Exercise price: $5.75 per share
Expiration date: June 4, 2036
+2 more
5 metrics
Options granted
71,666 options
Grant to director on June 4, 2026
Exercise price
$5.75 per share
Stock option strike price
Expiration date
June 4, 2036
Option term end
Vesting schedule
12 monthly installments
Beginning June 30, 2026
Post-transaction options held
71,666 options
Total derivative holdings after grant
Key Terms
Stock option, exercise price, vesting, Omnibus Incentive Plan, +1 more
5 terms
Stock option financial
"Stock option (right to buy)"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "5.7500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option will vest in twelve (12) equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Omnibus Incentive Plan financial
"Issuer's 2025 Omnibus Incentive Plan"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Turn Therapeutics (TTRX) report for Martin William Dewhurst?
Turn Therapeutics reported that director Martin William Dewhurst received a grant of 71,666 stock options. These options give him the right to buy Common Stock at $5.75 per share, subject to vesting and the company’s 2025 Omnibus Incentive Plan.
How many Turn Therapeutics (TTRX) stock options were granted to director Dewhurst?
Dewhurst was granted 71,666 stock options for Turn Therapeutics Common Stock. Each option allows purchase at an exercise price of $5.75 per share, with vesting spread over twelve monthly installments starting in June 2026.
When do Martin Dewhurst’s Turn Therapeutics (TTRX) stock options vest and expire?
The options vest in twelve equal monthly installments starting on June 30, 2026. All options expire on June 4, 2036, meaning they must be exercised before that date, assuming vesting and continued employment conditions are met.
What is the exercise price of the new Turn Therapeutics (TTRX) stock options granted?
The newly granted stock options have an exercise price of $5.75 per share. This is the price Dewhurst must pay to convert each vested option into one share of Turn Therapeutics Common Stock within the option term.
How many Turn Therapeutics (TTRX) options does Dewhurst hold after this Form 4 transaction?
After this transaction, Dewhurst holds 71,666 stock options directly. All these options relate to the new grant reported and are subject to the vesting schedule and conditions in the 2025 Omnibus Incentive Plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
